ALDH1A1 and prostate carcinoma: In general, they reported that the Wnt pathway, a significant pathway in CSCs, directly regulates ALDH1A1 level through β-catenin/TCF-dependent transcription as well as ALDH1A1 and β-catenin co-expression in prostate cancer cells.